Slightly more balanced article from SMH
disallowed/business/small-business/troubled-mesoblast-secures-crucial-cash-buffer-from-surprise-us-backer-20210302-p5770h.html
"Troubled drug developer Mesoblast has been given a financial lifeline analysts expect will give it an 18-month cash buffer after securing a $138 million investment from a surprise US backer.
The ASX-listed $1.45 billion stem cell treatments maker unveiled an unexpected new partner on Tuesday, confirming it had sealed a $US110 million ($138 million) deal with a US investor group led by surgery clinics business, SurgCenter Development."
Cell Therapy News/Articles, page-8445
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.013(1.07%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.19 | $1.17 | $1.349M | 1.149M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 113399 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 52219 | 12 |
View Market Depth
| Last trade - 11.12am 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |